These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 7046367)

  • 1. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A
    Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
    Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J
    Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients.
    Gelenberg AJ; Wojcik JD; Newell C; Lamping DL; Spring B
    J Clin Psychopharmacol; 1985 Feb; 5(1):30-4. PubMed ID: 3882774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 5. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
    Montgomery SA; Montgomery DB; McAuley R; Rani SJ; Roy D
    Adv Biochem Psychopharmacol; 1982; 32():35-42. PubMed ID: 6211942
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of bupropion and amitriptyline in depressed outpatients.
    Mendels J; Amin MM; Chouinard G; Cooper AJ; Miles JE; Remick RA; Saxena B; Secunda SK; Singh AN
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):118-20. PubMed ID: 6406439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of two new antidepressants.
    Gershon S; Georgotas A; Newton R; Bush D
    Adv Biochem Psychopharmacol; 1982; 32():57-68. PubMed ID: 6211943
    [No Abstract]   [Full Text] [Related]  

  • 8. WA 335 (danitracen): a preliminary evaluation of a potential antidepressant compound. A comparative double-blind study with WA 335 and amitriptyline in the treatment of depressive patients.
    Kaumeier S; Dohren J; Flach D
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):108-13. PubMed ID: 401705
    [No Abstract]   [Full Text] [Related]  

  • 9. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
    Hebenstreit GF; Fellerer K; Fichte K; Fischer G; Geyer N; Meya U; Sastre-y-Hernández M; Schöny W; Schratzer M; Soukop W
    Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
    Davidson J; Miller R; Van Wyck Fleet J; Strickland R; Manberg P; Allen S; Parrott R
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):115-7. PubMed ID: 6406438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine.
    Freeman HL; Wakelin JS; Calanca A; Hole G
    Adv Biochem Psychopharmacol; 1982; 32():69-75. PubMed ID: 7046368
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the antidepressant effects of a synthetic androgen (mesterolone) and amitriptyline in depressed men.
    Vogel W; Klaiber EL; Broverman DM
    J Clin Psychiatry; 1985 Jan; 46(1):6-8. PubMed ID: 3880735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant response and plasma concentrations of bupropion.
    Preskorn SH
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):137-9. PubMed ID: 6406443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of bupropion.
    Othmer E; Othmer SC; Stern WC; Van Wyck Fleet J
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):153-6. PubMed ID: 6406448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of bupropion in elderly patients: preliminary observations.
    Kane JM; Cole K; Sarantakos S; Howard A; Borenstein M
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary MHPG is not a good predictor of antidepressive drug response.
    Puzyński S; Rode A; Bidziński A; Mrozek S; Załuska M
    Pol J Pharmacol Pharm; 1984; 36(4):329-35. PubMed ID: 6527968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.
    Kuhs H; Rudolf GA
    Acta Psychiatr Scand Suppl; 1989; 350():145-6. PubMed ID: 2530773
    [No Abstract]   [Full Text] [Related]  

  • 18. Speed of onset of action of the newer antidepressants.
    Lydiard RB; Pottash AL; Gold MS
    Psychopharmacol Bull; 1984; 20(2):258-71. PubMed ID: 6374722
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical profile of the novel antidepressant bupropion.
    Stern WC; Harto-Truax N; Rogers J; Miller L
    Adv Biochem Psychopharmacol; 1982; 32():21-34. PubMed ID: 6807060
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative, multicenter trial between bromocriptine and amitriptyline in the treatment of endogenous depression.
    Theohar C; Fischer-Cornelssen K; Brosch H; Fischer EK; Petrovic D
    Arzneimittelforschung; 1982; 32(7):783-7. PubMed ID: 6751339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.